Gaois

Search direction

Search mode

Filter results

Collections

154 results in 6 documents

  1. #742883

    Beag beann ar a dtiocfaidh as an imscrúdú cliniciúil, laistigh de bhliain amháin ó thagann deireadh leis an imscrúdú cliniciúil nó laistigh de thrí mhí ó chuirtear deireadh luath nó stad sealadach leis, déanfaidh an t-urraitheoir tuarascáil ar an imscrúdú cliniciúil amhail dá dtagraítear i Roinn 2.8 de Chaibidil I agus i Roinn 7 de Chaibidil III d'Iarscríbhinn XV a chur faoi bhráid na mBallstát ina raibh imscrúdú cliniciúil á dhéanamh.

    Irrespective of the outcome of the clinical investigation, within one year of the end of the clinical investigation or within three months of the early termination or temporary halt, the sponsor shall submit to the Member States in which a clinical investigation was conducted a clinical investigation report as referred to in Section 2.8 of Chapter I and Section 7 of Chapter III of Annex XV.

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  2. #741800

    ciallaíonn “feiste imscrúdaitheach” feiste a ndéantar measúnú uirthi in imscrúdú cliniciúil;

    ‘investigational device’ means a device that is assessed in a clinical investigation;

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  3. #741803

    imscrúdú cliniciúilimscrúduithe cliniciúla ar an bhfeiste lena mbaineann,

    clinical investigation(s) of the device concerned,

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  4. #741808

    ciallaíonn “ábhar” duine aonair a ghlacann páirt in imscrúdú cliniciúil;

    ‘subject’ means an individual who participates in a clinical investigation;

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  5. #741812

    ciallaíonn “imscrúdaitheoir” duine aonair atá freagrach as imscrúdú cliniciúil a dhéanamh ag láithreán imscrúdaithe chliniciúil;

    ‘investigator’ means an individual responsible for the conduct of a clinical investigation at a clinical investigation site;

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  6. #741813

    ciallaíonn “toiliú feasach” nochtadh saor agus deonach an ábhair, gur toil leis nó léi páirt a ghlacadh in imscrúdú cliniciúil ar leith, tar éis dó nó di a bheith curtha ar an eolas faoi gach gné den imscrúdú cliniciúil atá ábhartha maidir le cinneadh an ábhair a bheith rannpháirteach nó, i gcás mionaoiseach agus ábhar atá ar éagumas, údarú nó comhaontú óna n-ionadaí a ainmnítear de réir dlí, go bhféadfar iad a áireamh san imscrúdú cliniciúil;

    ‘informed consent’ means a subject's free and voluntary expression of his or her willingness to participate in a particular clinical investigation, after having been informed of all aspects of the clinical investigation that are relevant to the subject's decision to participate or, in the case of minors and of incapacitated subjects, an authorisation or agreement from their legally designated representative to include them in the clinical investigation;

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  7. #742703

    Beidh na saoráidí ina ndéanfar an t-imscrúdú cliniciúil oiriúnach don imscrúdú cliniciúil agus beidh siad cosúil le saoráidí inar beartaíodh an fheiste a úsáid.

    The facilities where the clinical investigation is to be conducted shall be suitable for the clinical investigation and shall be similar to the facilities where the device is intended to be used.

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  8. #742735

    baineann an t-imscrúdú cliniciúil go díreach le riocht sláinte atá á fhulaingt ag an ábhar;

    the clinical investigation relates directly to a medical condition from which the subject suffers;

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  9. #742760

    De mhaolú ar phointe (f) d'Airteagal 62(4), ar phointe (a) agus ar phointe (b) d'Airteagal 64(1) agus ar phointe (a) agus ar phointe (b) d'Airteagal 65, féadfar toiliú feasach a fháil páirt a ghlacadh in imscrúdú cliniciúil, agus féadfar faisnéis maidir leis an imscrúdú cliniciúil a thabhairt, tar éis an cinneadh an ábhair a áireamh san imscrúdú cliniciúil ar choinníoll go ndéanfar an cinneadh sin tráth na chéad idirghabhála maidir leis an ábhair i gcomhréir leis an bplean maidir le himscrúdú cliniciúil agus go gcomhlíonfar na coinníollacha seo a leanas ar fad:

    By way of derogation from point (f) of Article 62(4), from points (a) and (b) of Article 64(1) and from points (a) and (b) of Article 65, informed consent to participate in a clinical investigation may be obtained, and information on the clinical investigation may be given, after the decision to include the subject in the clinical investigation, provided that that decision is taken at the time of the first intervention on the subject, in accordance with the clinical investigation plan for that clinical investigation and that all of the following conditions are fulfilled:

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  10. #742794

    Féadfaidh an t-urraitheoir an t-imscrúdú cliniciúil a thosú sna cúinsí seo a leanas:

    The sponsor may start the clinical investigation in the following circumstances:

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  11. #742822

    Mar a dhéanfar imscrúdú cliniciúil

    Conduct of a clinical investigation

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  12. #742867

    an t-údarú don imscrúdú cliniciúil a chúlghairm;

    revoke the authorisation for the clinical investigation;

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  13. #742868

    an t-imscrúdú cliniciúil a chur ar fionraí nó a fhoirceannadh;

    suspend or terminate the clinical investigation;

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  14. #742879

    Tabharfaidh an t-urraitheoir fógra do gach Ballstát ina raibh imscrúdú cliniciúil á dhéanamh maidir le deireadh a bheith curtha leis an imscrúdú cliniciúil sin sa Bhallstát sin.

    The sponsor shall notify each Member State in which a clinical investigation was being conducted of the end of that clinical investigation in that Member State.

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  15. #742882

    Tabharfar an fógra sin laistigh de 15 lá ó thagann deireadh leis an imscrúdú cliniciúil.

    That notification shall be made within 15 days of that end of the clinical investigation.

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  16. #742949

    Tuairisceoidh an t-urraitheoir freisin do na Ballstáit lena mbaineann ina bhfuil an t-imscrúdú cliniciúil á dhéanamh, trí mheán an chórais leictreonaigh dá dtagraítear in Airteagal 73, aon tarlú dá dtagraítear i mír 2 den Airteagal seo a tharla i dtríú tíortha ina bhfuil imscrúdú cliniciúil á dhéanamh faoin bplean céanna don imscrúdú cliniciúil agus an ceann a bhfuil feidhm aige i leith imscrúdaithe chliniciúil a chumhdaítear faoin Rialachán seo.

    The sponsor shall also report to the Member States in which the clinical investigation is being conducted any event referred to in paragraph 2 of this Article that occurred in third countries in which a clinical investigation is performed under the same clinical investigation plan as the one applying to a clinical investigation covered by this Regulation by means of the electronic system referred to in Article 73.

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  17. #744436

    an t-imscrúdú cliniciúil,

    the clinical investigation,

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  18. #745057

    DOICIMÉADACHT MAIDIR LEIS AN IARRATAS AR IMSCRÚDÚ CLINICIÚIL

    DOCUMENTATION REGARDING THE APPLICATION FOR CLINICAL INVESTIGATION

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  19. #745064

    stádas an iarratais ar imscrúdú cliniciúil (i.e. céadtíolacadh an iarratais, atíolacadh an iarratais, leasú suntasach);

    status of the clinical investigation application (i.e. first submission, resubmission, significant amendment);

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  20. #745074

    fianaise ón urraitheoir go bhfuil an t-imscrúdaitheoir cliniciúil agus an láthair imscrúdaitheach in ann imscrúdú cliniciúil a dhéanamh i gcomhréir leis an bplean don imscrúdú cliniciúil;

    evidence from the sponsor that the clinical investigator and the investigational site are capable of conducting the clinical investigation in accordance with the clinical investigation plan;

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  21. #745094

    Plean don Imscrúdú Cliniciúil

    Clinical Investigation Plan

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  22. #745117

    Faisnéis faoi aon leasuithe ar an bplean don imscrúdú cliniciúil.

    Information about any amendments to the CIP.

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  23. #1969909

    Imscrúdú cliniciúil ar fheistí leighis le haghaidh daoine - Dea-chleachtas cliniciúil (SO 14155:2020)”;

    Clinical investigation of medical devices for human subjects - Good clinical practice (ISO 14155:2020)’

    Commission Implementing Decision (EU) 2021/610 of 14 April 2021 amending Implementing Decision (EU) 2020/437 as regards harmonised standards on medical vehicles and their equipment, anaesthetic and respiratory equipment, biological evaluation of medical devices, packaging for terminally sterilised medical devices, sterilisation of health care products, clinical investigation of medical devices for human subjects, non-active surgical implants, medical devices utilising animal tissues and their derivatives, electroacoustics and medical electrical equipment

  24. #1969977

    Imscrúdú cliniciúil ar fheistí leighis le haghaidh daoine - Dea-chleachtas cliniciúil (ISO 14155:2020)”;

    Clinical investigation of medical devices for human subjects - Good clinical practice (ISO 14155:2020)’

    Commission Implementing Decision (EU) 2021/611 of 14 April 2021 amending Implementing Decision (EU) 2020/438 as regards harmonised standards on biological evaluation of medical devices, packaging for terminally sterilised medical devices, sterilisation of health care products and clinical investigation of medical devices for human subjects

  25. #742685

    tá an t-imscrúdú cliniciúil faoi réir údarú ó údarás inniúil an Bhallstáit nó na mBallstát ina bhfuil an t-imscrúdú cliniciúil le déanamh, i gcomhréir leis an Rialachán seo, mura rud é go sonraítear a mhalairt;

    the clinical investigation is the subject of an authorisation by the Member State(s) in which the clinical investigation is to be conducted, in accordance with this Regulation, unless otherwise stated;

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  26. #742715

    cearta agus ráthaíochtaí an ábhair maidir le cosaint an duine sin, go háirithe maidir le ceart an duine sin diúltú páirt a ghlacadh in imscrúdú cliniciúil agus maidir le ceart an duine sin tarraingt siar ón imscrúdú cliniciúil tráth ar bith gan dochar dó dá dheasca agus gan aon dualgas a bheith air réasúnú a thabhairt;

    the subject's rights and guarantees regarding his or her protection, in particular his or her right to refuse to participate in and the right to withdraw from the clinical investigation at any time without any resulting detriment and without having to provide any justification;

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  27. #742744

    tá sé beartaithe go ndéanfaidh an t-imscrúdú cliniciúil imscrúdú ar chóireálacha do riocht sláinte a bhíonn ar mhionaoisigh amháin nó tá an t-imscrúdú cliniciúil sár-riachtanach chun bailíochtú a dhéanamh ar shonraí a fuarthas ó imscrúduithe cliniciúla ar dhaoine a bhí in ann toiliú feasach a thabhairt nó ó mhodhanna eile taighde;

    the clinical investigation is intended to investigate treatments for a medical condition that only occurs in minors or the clinical investigation is essential with respect to minors to validate data obtained in clinical investigations on persons able to give informed consent or by other research methods;

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  28. #742748

    más rud é, le linn imscrúdú cliniciúil, go slánaíonn an mionaoiseach aois na hinniúlachta dlíthiúla chun toiliú feasach a thabhairt mar a shainmhínítear é sa dlí náisiúnta, gheofar toiliú feasach an mhionaoisigh sular féidir leis an ábhar sin leanúint de bheith rannpháirteach san imscrúdú cliniciúil.

    if during a clinical investigation the minor reaches the age of legal competence to give informed consent as defined in national law, his or her express informed consent shall be obtained before that subject can continue to participate in the clinical investigation.

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  29. #742767

    I ndiaidh idirghabháil de bhun mhír 1 den Airteagal seo, déanfar toiliú feasach a lorg i gcomhréir le hAirteagal 63 le go leanfadh an t-ábhar de bheith rannpháirteach san imscrúdú cliniciúil agus tabharfar faisnéis faoin imscrúdú cliniciúil, i gcomhréir leis na ceanglais seo a leanas:

    Following an intervention pursuant to paragraph 1 of this Article, informed consent in accordance with Article 63 shall be sought to continue the participation of the subject in the clinical investigation, and information on the clinical investigation shall be given, in accordance with the following requirements:

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  30. #742779

    Cuirfear an t-iarratas isteach trí bhíthin an córas leictreonach dá dtagraítear in Airteagal 73, lena nginfear uimhir aitheantais aonair uile-Aontais don imscrúdú cliniciúil sin a úsáidfear le haghaidh gach cumarsáide ábhartha i ndáil leis an imscrúdú cliniciúil sin.

    The application shall be submitted by means of the electronic system referred to in Article 73, which shall generate a Union-wide unique single identification number for the clinical investigation, which shall be used for all relevant communication in relation to that clinical investigation.

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  31. #742824

    Chun a áirithiú go ndéanfar cearta, sábháilteacht agus dea-bhail na n-ábhar a chosaint, agus go ndéanfar an t-imscrúdú cliniciúil i gcomhréir le ceanglais an Rialacháin seo, áiritheoidh an t-urraitheoir go ndéanfar faireachán leordhóthanach ar an gcaoi a ndéantar imscrúdú cliniciúil.

    In order to verify that the rights, safety and well-being of subjects are protected, that the reported data are reliable and robust, and that the conduct of the clinical investigation is in compliance with the requirements of this Regulation, the sponsor shall ensure adequate monitoring of the conduct of a clinical investigation.

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  32. #742856

    Má tá sé ar intinn ag urraitheoir modhnuithe a dhéanamh ar imscrúdú cliniciúil ar cosúil go mbeidh tionchar substaintiúil acu ar shábháilteacht, ar shláinte nó ar chearta na n-ábhar don imscrúdú nó ar stóinseacht nó ar iontaofacht na sonraí cliniciúla a ghinfear san imscrúdú, tabharfaidh sé fógra, laistigh de sheachtain, tríd an gcóras leictreonach dá dtagraítear in Airteagal 73, don Bhallstát nó do na Ballstáit ina bhfuil an t-imscrúdú cliniciúil á dhéanamh, nó inambeid hsé le déanamh faoi na cúiseanna atá leis na modhnuithe sin agus a bhfuil i gceist leo.

    If a sponsor intends to introduce modifications to a clinical investigation that are likely to have a substantial impact on the safety, health or rights of the subjects or on the robustness or reliability of the clinical data generated by the investigation, it shall notify, within one week, by means of the electronic system referred to in Article 73 the Member State(s) in which the clinical investigation is being or is to be conducted of the reasons for and the nature of those modifications.

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  33. #742876

    Má stad an t-urraitheoir imscrúdú cliniciúil go sealadach nó má chuir sé deireadh luath leis, cuirfidh sé in iúl don Bhallstát inar cuireadh stad sealadach nó deireadh luath leis an imscrúdú cliniciúil sin, laistigh de 15 lá, tríd an gcóras leictreonach dá dtagraítear in Airteagal 73, gur cuireadh stad sealadach nó deireadh luath leis an imscrúdú, agus míneoidh sé na cúiseanna a bhí leis.

    If the sponsor has temporarily halted a clinical investigation or has terminated a clinical investigation early, it shall inform within 15 days the Member State in which that clinical investigation has been temporarily halted or terminated early, through the electronic system referred to in Article 73, of the temporary halt or early termination, providing a justification.

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  34. #742881

    Má dhéantar imscrúdú i níos mó ná Ballstát amháin, tabharfaidh an t-urraitheoir fógra do gach Ballstát ina raibh an t-imscrúdú cliniciúil sin á dhéanamh maidir le deireadh a bheith curtha leis an imscrúdú cliniciúil sna Ballstáit go léir.

    If an investigation is conducted in more than one Member State, the sponsor shall notify all Member States in which that clinical investigation was conducted of the end of the clinical investigation in all Member States.

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  35. #742923

    Diúltóidh Ballstát lena mbaineann imscrúdú cliniciúil a údarú má easaontaíonn sé le conclúid an Bhallstáit comhordúcháin maidir le haon fhoras dá dtagraítear sa dara fomhír de mhír 8, nó má fheictear dó, ar fhorais chuí-réasúnaithe, nach bhfuil na gnéithe ar a dtugtar aghaidh i Ranna 1.13, 3.1.3, 4.2, 4.3 agus 4.4 de Chaibidil II d'Iarscríbhinn XV á gcomhlíonadh nó más iomchuí, i gcás ina bhfuil tuairim dhiúltach eisithe ag coiste eitice maidir leis an imscrúdú cliniciúil sin atá bailí, i gcomhréir leis an dlí náisiúnta, don Bhallstát ina iomláine.

    A Member State concerned shall refuse to authorise a clinical investigation if it disagrees with the conclusion of the coordinating Member State as regards any of the grounds referred to in the second subparagraph of paragraph 8, or if it finds, on duly justified grounds, that the aspects addressed in Sections 1.13, 3.1.3, 4.2, 4.3 and 4.4 of Chapter II of Annex XV are not complied with, or where an ethics committee has issued a negative opinion in relation to that clinical investigation, which is valid, in accordance with national law, for that entire Member State.

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  36. #745072

    achoimre ar an bplean don imscrúdú cliniciúil lena n-áirítear cuspóir nó cuspóirí an imscrúdaithe chliniciúil, líon agus inscne na n-ábhar don tástáil, critéir maidir le roghnú na n-ábhar don tástáil, an bhfuil na hábhair don tástáil faoi 18 mbliana d'aois, dearadh an imscrúdaithe amhail staidéir rialaithe agus/nó randamaithe, na dátaí ar a bhfuil sé beartaithe tús a chur leis an imscrúdú cliniciúil agus é a chríochnú;

    summary of the clinical investigation plan including the objective or objectives of the clinical investigation, the number and gender of subjects, criteria for subject selection, whether there are subjects under 18 years of age, design of the investigation such as controlled and/or randomised studies, planned dates of commencement and of completion of the clinical investigation;

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  37. #745125

    Tuairisc ar na socruithe maidir le cúram do na hábhair tar éis deireadh teacht lena rannpháirteachas san imscrúdú cliniciúil, i gcás ina mbeidh gá le breischúram den sórt sin de thoradh rannpháirteachas na n-ábhar san imscrúdú cliniciúil agus i gcás nach ionann é agus an cúram a mbeifí ag súil leis de ghnáth don riocht sláinte atá i dtrácht.

    A description of the arrangements for taking care of the subjects after their participation in the clinical investigation has ended, where such additional care is necessary because of the subjects' participation in the clinical investigation and where it differs from that normally expected for the medical condition in question.

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  38. #2569183

    Táirge a bhfuil sé beartaithe ag an monaróir imscrúdú cliniciúil a dhéanamh ina leith, nó a bhfuil imscrúdú cliniciúil á dhéanamh aige chun sonraí cliniciúla a ghiniúint don mheastóireacht chliniciúil chun a dheimhniú go bhfuil comhlacht dá dtugtar fógra i gcomhréir leis na ceanglais ghinearálta sábháilteachta agus feidhmíochta ábhartha a leagtar amach in Iarscríbhinn I a ghabhann le Rialachán (AE) 2017/745 agus leis na sonraíochtaí comhchoiteanna a leagtar amach sa Rialachán seo, agus leis an measúnú comhréireachta nach mór do chomhlacht dá dtugtar fógra a bheith bainteach leis i gcomhréir le hAirteagal 52 den Rialachán sin, féadfar é a chur ar an margadh nó a chur i seirbhís go dtí an 22 Meitheamh 2028, ar choinníoll go gcomhlíonfar na coinníollacha seo a leanas:

    A product for which the manufacturer intends to perform, or is performing, a clinical investigation to generate clinical data for the clinical evaluation in order to confirm the conformity with the relevant general safety and performance requirements set out in Annex I to Regulation (EU) 2017/745 and the common specifications set out in this Regulation, and in the conformity assessment of which a notified body has to be involved in accordance with Article 52 of that Regulation, may be placed on the market or put into service until 22 June 2028, provided that the following conditions are met:

    Commission Implementing Regulation (EU) 2022/2346 of 1 December 2022 laying down common specifications for the groups of products without an intended medical purpose listed in Annex XVI to Regulation (EU) 2017/745 of the European Parliament and of the Council on medical devices (Text with EEA relevance)

  39. #2569186

    De mhaolú ar an gcéad fhomhír den mhír seo, ó 22 Meitheamh 2024 go dtí an 22 Nollaig 2024, ní fhéadfar táirge a chomhlíonann na coinníollacha a leagtar síos san fhomhír sin a chur ar an margadh nó i seirbhís ach amháin má fuair an t-urraitheoir fógra ón mBallstát lena mbaineann, i gcomhréir le hAirteagal 70(1) nó (3) de Rialachán (AE) 2017/745, lena ndeimhnítear go bhfuil an t-iarratas ar imscrúdú cliniciúil an táirge críochnaithe agus go dtagann an t-imscrúdú cliniciúil faoi raon feidhme Rialachán (AE) 2017/745.

    By way of derogation from the first subparagraph of this paragraph, from 22 June 2024 until 22 December 2024, a product that meets the conditions laid down in that subparagraph may only be placed on the market or put into service, if the sponsor has received from the Member State concerned a notification, in accordance with Article 70(1) or (3) of Regulation (EU) 2017/745, confirming that the application for the clinical investigation of the product is complete and that the clinical investigation falls within the scope of the Regulation (EU) 2017/745.

    Commission Implementing Regulation (EU) 2022/2346 of 1 December 2022 laying down common specifications for the groups of products without an intended medical purpose listed in Annex XVI to Regulation (EU) 2017/745 of the European Parliament and of the Council on medical devices (Text with EEA relevance)

  40. #741605

    Ba cheart go bhféadfadh an monaróir agus duine nádúrtha nó dlítheanach eile, ar aon, a bheith ina urraitheoir a ghlacann freagracht as an imscrúdú cliniciúil.

    It should be possible both for the manufacturer and for another natural or legal person to be the sponsor taking responsibility for the clinical investigation.

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  41. #741616

    I gcás ina bhfuil imscrúdú cliniciúil le déanamh i níos mó ná Ballstát amháin, ba cheart caoi a thabhairt don urraitheoir iarratas aonair a thíolacadh chun an t-ualach riaracháin a laghdú.

    Where a clinical investigation is to be conducted in more than one Member State, the sponsor should have the possibility of submitting a single application in order to reduce administrative burden.

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  42. #741799

    ciallaíonn “imscrúdú cliniciúil” aon imscrúdú córasach lena mbaineann ábhar amháin nó níos mó is duine, a dhéantar chun sábháilteacht nó feidhmíocht feiste a mheas;

    ‘clinical investigation’ means any systematic investigation involving one or more human subjects, undertaken to assess the safety or performance of a device;

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  43. #741804

    imscrúdú cliniciúilimscrúdaithe cliniciúla nó staidéir eile a bhfuil trácht orthu i litríocht eolaíoch, ar fheiste den chineál céanna ar féidir a coibhéis leis an bhfeiste atá i gceist a thaispeáint,

    clinical investigation(s) or other studies reported in scientific literature, of a device for which equivalence to the device in question can be demonstrated,

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  44. #741807

    ciallaíonn “urraitheoir” aon duine aonair, cuideachta, institiúid nó eagraíocht a ghlacann freagracht as imscrúdú cliniciúil a thionscnamh agus a bhainistiú agus freisin as maoiniú an imscrúdaithe chliniciúil a chur ar bun;

    ‘sponsor’ means any individual, company, institution or organisation which takes responsibility for the initiation, for the management and setting up of the financing of the clinical investigation;

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  45. #742661

    Beidh meastóireachtaí cliniciúla ar na táirgí sin bunaithe ar shonraí ábhartha a bhaineann leis an tsábháilteacht, lena n-áirítear sonraí ón bhfaireachas iarmhargaidh, MLFI agus, i gcás inarb infheidhme, imscrúdú cliniciúil sonrach.

    Clinical evaluations of those products shall be based on relevant data concerning safety, including data from post-market surveillance, PMCF, and, where applicable, specific clinical investigation.

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  46. #742684

    Féadfar imscrúdú cliniciúil amhail dá dtagraítear i mír 1 a dhéanamh i gcás ina gcomhlíonfar na coinníollacha uile seo a leanas agus sa chás sin amháin:

    A clinical investigation as referred to in paragraph 1 may be conducted only where all of the following conditions are met:

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  47. #742686

    ní dhearna coiste eitice, arna bhunú i gcomhréir leis an dlí náisiúnta, tuairim dhiúltach a eisiúint maidir leis an imscrúdú cliniciúil, atá bailí don Bhallstát sin ina iomláine faoina dhlí náisiúnta;

    an ethics committee, set up in accordance with national law, has not issued a negative opinion in relation to the clinical investigation, which is valid for that entire Member State under its national law;

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  48. #742716

    na coinníollacha faoina ndéanfar na himscrúduithe cliniciúla, lena n-áirítear fad ama measta rannpháirtíochta an ábhair san imscrúdú cliniciúil; agus

    the conditions under which the clinical investigations is to be conducted, including the expected duration of the subject's participation in the clinical investigation; and

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  49. #742717

    na cóireálacha eile a d'fhéadfadh a bheith i gceist, lena n-áirítear na bearta leantacha má thagann deireadh le rannpháirtíocht an ábhair san imscrúdú cliniciúil;

    the possible treatment alternatives, including the follow-up measures if the participation of the subject in the clinical investigation is discontinued;

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )

  50. #742740

    Ní fhéadfar imscrúdú cliniciúil a dhéanamh ar mhionaoisigh ach amháin má chomhlíontar na coinníollacha seo a leanas ar fad, de bhreis ar na coinníollacha a leagtar amach in Airteagal 62(4):

    A clinical investigation on minors may be conducted only where, in addition to the conditions set out in Article 62(4), all of the following conditions are met:

    Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )